In addition, these novel findings imply that AQP4 may function as a new therapeutic target if it is directly involved in Th polarization pathways within immune system cells by modulating CD4+ T cell responses for schistosomiasis or other immune-associated diseases. This evidence concerns the gene CD4 and schistosomiasis.